- Home
- Life Sciences
- Pharmaceutical
- Drug and Medication
- Drug and Medication Analysis & Statistics in France, January 2013 (p3)
Talk to Alison
00 1 718 618 48 97
Search inside this page
Publication dates
Publishers
- Global Data (39)
- Global Research & Data Services (7)
- Business Monitor International (24)
- Datamonitor (20)
- VacZine Analytics Group Of Assay Advantage Ltd (10)
-
- Euromonitor International (5)
- ICD Research (4)
- SCRIP Insights (3)
- Business Review (2)
- Firstword Pharma (2)
- GBI Research (2)
- Global Industry Analyst (2)
- Barnes Reports (1)
- Daedal Research (1)
- DrugPatentWatch - ThinkBiotech LLC (1)
- Espicom Business Intelligence (1)
- Ken Research Private (1)
- Koncept Analytics (1)
- MarketLine (1)
- Urch Publishing (1)
- Visiongain (1)
- World Market Intelligence Ltd (1)
data types
Free Market Research Guides to Download
Drug and Medication Analysis & Statistics in France, January 2013 (p3)
You might be interested in: drug, vaccine, insulin, more »
» Purchase Premium Reports
61-100 of about 100 reports
France Vaccine Exports, Eurmn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Vaccine Exports, Eurmn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Vaccine Imports, Us$mn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Vaccine Imports, Eurmn
- $ 250
- Industry data
- January 2013
Yearly, From 2002 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Vaccine Exports, Us$mn, % Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2003 To 2010
By Business Monitor International
Source: United Nations Comtrade Database DESA/UNSD, BMI
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales, % Of Gdp
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales, Eurbn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2005 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales At Constant Exchange Rate, Us$bn
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales, Us$ Per Capita
- $ 250
- Industry data
- January 2013
Yearly, From 2004 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
France Pharmaceutical Sales, Us$bn, % Chg Y-o-y
- $ 250
- Industry data
- January 2013
Yearly, From 2005 To 2021
By Business Monitor International
Source: LEEM (les entreprises du m?dicament), Association of the European Self-Medication Industry (AESGP),
- Industries : Drug and Medication
- Countries : France
Drug and Medication: Hepatitis B Vaccines
- $ 3 500
- Industry report
- October 2011
- by Global Data
GlobalData, the market analysis specialist, has released its new report, ?Hepatitis B - Pipeline Assessment and Industry Projections to 2017?. The report is an essential source of information and analysis ...
- Industries : Drug and Medication
- Countries : World, Japan, Spain, Italy, France, Germany, United States, Europe, United Kingdom
Drug and Medication in Italy: 5EU: Pricing, Reimbursment and Regulatory Update
- $ 1 900
- Industry report
- October 2011
- by Datamonitor
About This Report Governments across the five major EU industry s (France, Germany, Italy, Spain, and the UK) have been busy implementing regulatory, pricing, and reimbursement reforms in 2011. Price cuts ...
- Industries : Drug and Medication
- Countries : Italy, Spain, Germany, France, Europe, United Kingdom
World Biopharmaceutical: Cancer Vaccines
- $ 3 500
- Industry report
- October 2011
- by Global Data
The report identifies major industry developments shaping and driving the global Atopic dermatitis disease industry . It also provides insight on the prevalent competitive landscape and the emerging players ...
- Industries : Drug and Medication
- Countries : Japan, Spain, Italy, France, Germany, World, United States, Europe, United Kingdom
Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- $ 3 500
- Industry report
- October 2011
- by Global Data
Influenza Vaccines Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, ?Influenza Vaccines Therapeutics - ...
- Industries : Drug and Medication
- Countries : Japan, Spain, Italy, France, Germany, World, United States, Europe, United Kingdom
Product Profiles: HIV - Growing number of FDCs further commoditizes the HIV industry
- $ 11 400
- Industry report
- October 2011
- by Datamonitor
About This Report Gilead's/Bristol-Myers Squibb's Atripla was the first industry ed cross-class fixed dose combination (FDC), an antiretroviral drug class in which drugs from different drug classes are ...
- Industries : Drug and Medication
- Countries : Spain, Italy, France, Germany, Europe, United States, United Kingdom
Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020 Summary GlobalData's pharmaceuticals report, ?Selexipag (ACT-293987, NS-304) - Analysis and Forecasts from 2015 to 2020? provides ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?Macitentan (ACT-064992) - Analysis and Forecasts from 2013 to 2020? provides Macitentan ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020 Summary GlobalData's pharmaceuticals report, ?Letairis/Volibris (ambrisentan) - Analysis and Forecasts from 2007 to 2020? provides ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020 Summary GlobalData's pharmaceuticals report, ?Veletri (epoprostenol) - Analysis and Forecasts from 2010 to 2020? provides Veletri sales ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020 Summary GlobalData's pharmaceuticals report, ?Adcirca (tadalafil) - Analysis and Estimates from 2009 to 2020? provides Adcirca sales estimates ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020 Summary GlobalData's pharmaceuticals report, ?Revatio (sildenafil)- Analysis and Estimates from 2005 to 2020? provides Revatio sales estimates ...
- Industries : Drug and Medication
- Countries : Japan, World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017
- $ 2 000
- Industry report
- October 2011
- by Global Data
Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017 Summary GlobalData's pharmaceuticals report, ?Ventavis (iloprost) - Analysis and Estimates from 2003 to 2017? provides Ventavis sales estimates ...
- Industries : Drug and Medication
- Countries : World, United States, Spain, Italy, France, Germany, Europe, United Kingdom, Japan
Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020 Summary GlobalData's pharmaceuticals report, ?Tracleer (bosentan) - Analysis and Forecasts from 2002 to 2020? provides Tracleer sales estimates ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Gleevec - Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Gleevec - Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?Gleevec - Analysis and Forecasts from 2013 to 2020? provides Gleevec sales estimates for US, EU5 and Japan. ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Remodulin - Analysis and Forecasts from 2002 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Remodulin - Analysis and Forecasts from 2002 to 2020 Summary GlobalData's pharmaceuticals report, ?Remodulin - Analysis and Forecasts from 2002 to 2020? provides Remodulin sales estimates for US, EU5 and ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Riociguat - Analysis and Forecasts from 2013 to 2020
- $ 2 000
- Industry report
- October 2011
- by Global Data
Riociguat - Analysis and Forecasts from 2013 to 2020 Summary GlobalData's pharmaceuticals report, ?Riociguat - Analysis and Forecasts from 2013 to 2020? provides Riociguat sales estimates for US, EU5 and ...
- Industries : Drug and Medication
- Countries : World, Japan, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Ginger S.A. (Symbol:GNG) SWOT Analysis, Strategy, Revenues and Profits
- $ 250
- Company report
- September 2011
- by Global Data
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
- Industries : Drug and Medication
- Countries : France
Boiron SA: Company Profile and SWOT Analysis
- $ 99
- Company report
- September 2011
- by ICD Research
Synopsis ICD Research's "Boiron SA: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, ...
- Industries : Drug and Medication
- Countries : Czech Republic, Italy, France, Europe, United States, Switzerland, Brazil, Canada, Russian Federation, Portugal, Poland, Hungary, Belgium, World
Pharmaceuticals - France
- $ 652
- Industry report
- September 2011
- by Global Research & Data Services
This market analysis gives an overview of the actual situation, trends and future outlook of the pharmaceutical market in France. The market analysis provides essential market information for decision-makers ...
- Industries : Drug and Medication
- Countries : France
Cough and Cold Preparations Industry Overview in France to 2014 (OTC Healthcare)
- $ 350
- Industry report
- February 2011
- by Datamonitor
About This Report This databook provides key data and information on the Cough and Cold Preparations Industry in France (OTC Healthcare). This market research report is a comprehensive resource for industry, ...
- Industries : Drug and Medication
- Countries : France
Analgesics Industry Overview in France to 2014 (OTC Healthcare)
- $ 350
- Industry report
- February 2011
- by Datamonitor
About This Report This databook provides key data and information on the Analgesics Industry in France (OTC Healthcare). This market research report is a comprehensive resource for industry, category and ...
- Industries : Drug and Medication
- Countries : France
Antibacterials: Statistics and Forecast
- $ 15 200
- Industry report
- February 2011
- by Datamonitor
About This Report Over the next decade, the fragmented antibacterials industry will shift away from a blockbuster-business model, as generic erosion of industry leaders and increased competition between ...
- Industries : Drug and Medication
- Countries : Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom
Drug and Medication in Japan: Pipeline and Commercial Insight: Neuropathic Pain - Pipeline setbacks prolong Pfizer's supremacy
- $ 15 200
- Industry report
- January 2011
- by Datamonitor
About This Report At present, only six drugs are indicated for the treatment of neuropathic pain. In 2010, two significant events impacted the neuropathic pain industry : the launch of Qutenza (8% capsaicin ...
- Industries : Drug and Medication
- Countries : Japan, United States, Spain, Italy, France, Germany, Europe
Neuropathic Pain Statistics and Forecast
- $ 15 200
- Industry report
- January 2011
- by Datamonitor
About This Report At present, only six drugs are indicated for the treatment of neuropathic pain. In 2010, two significant events impacted the neuropathic pain industry : the launch of Qutenza (8% capsaicin ...
- Industries : Drug and Medication
- Countries : United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
MarketVIEW: Pseudomonas aeruginosa vaccines
- $ 7 995
- Industry report
- January 2011
- by VacZine Analytics Group Of Assay Advantage Ltd
Gram-positive Pseudomonas aeruginosa (PA) is primarily a nosocomial pathogen accounting for around 10% of all hospital acquired infections second only toStaphylococcus aureus . PA infections are invasive ...
- Industries : Drug and Medication
- Countries : United States, Australia, Canada, United Kingdom, Spain, Italy, France, Germany, Japan, Europe
2011 Worldwide Pharmaceutical Preparation Mfg. Industry Report
- $ 249
- Industry report
- December 2010
- by Barnes Reports
The Pharmaceutical Preparation Mfg. Industry report, published annually by Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2011 current ...
- Industries : Drug and Medication
- Countries : World, Argentina, Brazil, Mexico, Canada, Russian Federation, Italy, France, Germany, South Korea, Japan, India, China, Europe, United Kingdom, South America, Africa, Asia, North America
Boiron SA: SWOT Analysis & Company Profile
- $ 99
- Company report
- November 2010
- by Business Review
Synopsis Business Review's Boiron SA contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company. Summary This SWOT Analysis company profile ...
- Industries : Drug and Medication
- Countries : Czech Republic, Italy, France, Europe, United States, Switzerland, Brazil, Canada, Russian Federation, Portugal, Poland, Hungary, Belgium, World
Les Laboratoires Servier: Company Analysis (Strategy, Portfolio and Pipeline Analysis) e
- $ 5 700
- Industry report
- November 2010
- by Datamonitor
About This Report This analysis examines the historical and projected performance for Servier in the prescription pharmaceutical segment . The report includes global corporate vision and strategy, portfolio ...
- Industries : Drug and Medication
- Countries : France
Boiron SA SWOT
- $ 175
- Company report
- November 2010
- by MarketLine
examines the firm ?s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Boiron is a France-based pharmaceutical group specializing ...
- Industries : Drug and Medication
- Countries : France
Biopharmaceutical in United States: Pipeline and Commercial Insight: Pneumococcal and Meningococcal Vaccines
- $ 15 200
- Industry report
- October 2010
- by Datamonitor
About This Report Over the next decade, Pfizer's Prevnar 13 is set to dominate the pneumococcal vaccine industry with sales that could reach USD 3.4 billion in infants and adults across the US and 5EU ...
- Industries : Drug and Medication
- Countries : United States, Europe, Japan, Spain, Italy, France, Germany, World, United Kingdom
» Download Public Reports
50 reports
Company Report: Drug and Medication in France and The United States for Year 2012
- Company report
- July 2012
- 2 pages
... And development, future clinical data and analysis, including post marketing, s by regulatory authorities, such as the fda or the ema, regarding whether and when to approve any drug, device or biological ...
Company Report: Drug And Medication In France For Year 2012
September 2012The European Medicine Industry Brief
May 2012The French Antibiotic Industry Analysis
October 2012Vaccine Market In The United States And France
September 2012Drug Sector In France
March 2013» Read our Company Profiles
1 CompaniesGlaxoSmithKline P.L.C.
United StatesReportlinker.com © Copyright 2013. All rights reserved.
